We are live on ! Find out more
Wolverine Trading

Wolverine Trading Portfolio holdings

AUM $139B
1-Year Est. Return 31.83%
This Fund
S&P 500
This Quarter Est. Return
+13.45%
1 Year Est. Return
+31.83%
3 Year Est. Return
+143.85%
5 Year Est. Return
+179.05%
10 Year Est. Return
AUM
$95.7B
AUM Growth
-$1.53B
Cap. Flow
+$1.74B
Cap. Flow %
1.82%
Top 10 Hldgs %
42.25%
Holding
5,465
New
1,072
Increased
1,724
Reduced
1,607
Closed
1,046

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.92%
2 Technology 3.03%
3 Consumer Discretionary 1.53%
4 Communication Services 1.18%
5 Financials 0.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVRD
4376
CALL
Tvardi Therapeutics
TVRD
$23.1M
$18.6K ﹤0.01%
694
+69
+11% +$2.86K
AQMS icon
4377
CALL
Aqua Metals
AQMS
$8.05M
$18.5K ﹤0.01%
122
+2
+2% +$356
SENS icon
4378
PUT
Senseonics Holdings Inc
SENS
$479M
$17.6K ﹤0.01%
1,540
-10
-0.6% -$114
LODE icon
4379
CALL
Comstock
LODE
$189M
$17.5K ﹤0.01%
3,200
+550
+21% +$2.52K
KPTI icon
4380
CALL
Karyopharm Therapeutics
KPTI
$38.6M
$17.2K ﹤0.01%
1,327
-33
-2% -$445
GOSS icon
4381
CALL
Gossamer Bio
GOSS
$67M
$16.8K ﹤0.01%
230
+64
+39% +$3.78K
VRM icon
4382
PUT
Vroom Inc
VRM
$53.1M
$16.8K ﹤0.01%
348
-25
-7% -$1.63K
IMUX icon
4383
Immunic
IMUX
$138M
$16.4K ﹤0.01%
+1,093
New +$13.4K
PGY icon
4384
Pagaya Technologies
PGY
$1.81B
$15.9K ﹤0.01%
962
-505
-34% -$8.23K
OGI
4385
CALL
Organigram Holdings
OGI
$153M
$15.9K ﹤0.01%
12,100
-18,800
-61% -$23.1K
LICY
4386
CALL
DELISTED
Li-Cycle Holdings Corp.
LICY
$15.6K ﹤0.01%
+3,325
New +$37.8K
ACB
4387
PUT
Aurora Cannabis
ACB
$242M
$15.5K ﹤0.01%
3,250
+2,060
+173% +$9.94K
CLOV icon
4388
Clover Health Investments
CLOV
$2.42B
$15.5K ﹤0.01%
16,228
+207
+1% +$203
REI icon
4389
Ring Energy
REI
$386M
$15.1K ﹤0.01%
10,342
-1,606
-13% -$2.64K
VERU icon
4390
CALL
Veru
VERU
$39.6M
$15K ﹤0.01%
2,090
+300
+17% +$2.66K
SHCR
4391
CALL
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$14.6K ﹤0.01%
+13,500
New +$13.8K
QVCGA
4392
PUT
DELISTED
QVC Group Inc Series A
QVCGA
$13.8K ﹤0.01%
316
-270
-46% -$9.26K
HYLN icon
4393
Hyliion Holdings
HYLN
$704M
$13.6K ﹤0.01%
+16,704
New +$11.9K
OTLY
4394
PUT
Oatly Group
OTLY
$391M
$13.2K ﹤0.01%
+560
New +$9.23K
RGTI icon
4395
CALL
Rigetti Computing
RGTI
$4.94B
$13.1K ﹤0.01%
13,300
+2,800
+27% +$3.19K
NSTG
4396
PUT
DELISTED
NanoString Technologies, Inc.
NSTG
$13K ﹤0.01%
+17,400
New +$18.4K
SMSI icon
4397
Smith Micro Software
SMSI
$16M
$12.6K ﹤0.01%
380
-593
-61% -$22K
AKBA icon
4398
PUT
Akebia Therapeutics
AKBA
$254M
$12.4K ﹤0.01%
+10,000
New +$10.2K
RGTI icon
4399
PUT
Rigetti Computing
RGTI
$4.94B
$11.3K ﹤0.01%
11,500
-17,000
-60% -$19.4K
XFOR icon
4400
PUT
X4 Pharmaceuticals
XFOR
$348M
$11.2K ﹤0.01%
447
+97
+28% +$2.36K

Similar funds

Wolverine Trading's Q4 2023 Portfolio in Review

As of Q4 2023, Wolverine Trading held 5,465 positions worth $95.7B, down 1.6% from $97.2B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Wolverine Trading's Q4 2023 filing shows 1,072 new, 1,724 increased, 1,607 reduced and 1,046 closed positions. Its largest new stake was Amgen: 146,510 shares worth $42.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $313M.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, down from 96% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Wolverine Trading's largest Q4 2023 buy was Amgen: 146,510 shares worth $42.2M.
  • Wolverine Trading added most to Amazon in Q4 2023, an estimated $726M increase.
  • Wolverine Trading's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $313M.
  • Wolverine Trading fully exited State Street SPDR Dow Jones Industrial Average ETF Trust in Q4 2023, selling an estimated $35.5M.
  • Wolverine Trading's ten largest holdings make up 42% of its $95.7B portfolio in Q4 2023.
  • Wolverine Trading opened 1,072 new positions and closed 1,046 in Q4 2023.
  • Wolverine Trading's portfolio value fell 1.6% quarter-over-quarter to $95.7B.

Based on Wolverine Trading's 13F filing for Q4 2023, filed 14 Feb 2024.